GlassScriptPhysician profile
Elise R Diamond
NPI 1467806422
$1,688.92
in general payments reported to CMS, 2019-2025
23 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $154 · 2022: $599 · 2023: $264 · 2024: $455 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $216.89 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $215.34 | 2021-2024 | |
| Aspira Women'S Health INC | $203.09 | 2022-2025 | Ova1 |
| Optumhealth Care Solutions, LLC | $184.84 | 2023-2025 | Vivify Health Care Team Portal 001, Eitan Medical, Zyno Solutions |
| Exeltis, USA INC. | $128.19 | 2022-2024 | Slynd |
| Organon LLC | $113.39 | 2021-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $109.55 | 2021-2025 | |
| Abbvie INC. | $92.66 | 2022-2024 | |
| Kerecis Limited | $70.88 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Coopersurgical, INC. | $52.29 | 2022-2025 | Paragard T 380a |
| Avion Pharmaceuticals | $48.32 | 2021-2022 | |
| Therapeuticsmd, INC. | $37.89 | 2021-2022 | |
| Sage Therapeutics, LLC | $33.74 | 2022-2024 | |
| Dexcom, INC. | $24.01 | 2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $23.54 | 2024 | Freestyle Libre 3 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $22.04 | 2021 | |
| Exact Sciences Corporation | $21.42 | 2024 | Cologuard Collection Kit |
| Davol INC. | $20.21 | 2025 | Arista |
| Hologic INC | $18.39 | 2021 | |
| Scynexis, INC. | $17.23 | 2022 | |
| Pfizer INC. | $14.22 | 2024 | |
| Evofem Biosciences, INC. | $11.55 | 2021 | |
| Qorumpartners | $9.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise Diamond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.